Drug Discovery News
-
Singapore firm, Stehlin Foundation collaborate on anti-cancer drug
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 15 Oct, 2013
Singapore: NanoMaterials Technology (NMT), a Singapore based company, has signed an exclusive material supply agreement with Houston-based CHRISTUS Stehlin Foundation for Cancer Research (S...Read more
-
AseaCyte gets BioSpectrum award for drug discovery efforts
Drug Discovery | Influencers | By BioSpectrum Bureau | 0 Comment | 15 Mar, 2013
A meeting between Dr Teo Soo Hwang, current CEO of AseaCyte; Dr Lee Hong Boon from Cancer Research Initiatives Foundation (CARIF), a non-profit cancer research institute in Malaysia; and Dr...Read more
-
Abraxane cancer trial shows positive results in Australia
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 29 Oct, 2012
Singapore: Specialised Therapeutics Australia (STA) is going to publish abstracts related to its phase III metastatic melanoma study with Abraxane (nanoparticle albumin-bound paclitaxel) at...Read more
-
Astellas, Ambit terminate cancer drug deal
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 12 Mar, 2013
Singapore: Japan-based Astellas Pharma and US-headquartered Ambit Biosciences are ending their collaboration for joint development and commercialization of FMS-like tyrosine kinase-3 (FLT3)...Read more
-
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 18 Dec, 2013
Singapore: Roche has launched FLOW system, a user defined system for workflow chain from primary sample handling to qPCR result analysis, for use in laboratory developed tests (LDT) in Euro...Read more
-
TB prevention faces gap of $1.6bn: WHO estimates
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2013
Singapore: WHO and Global Fund to Fight AIDS, TB and Malaria have stressed on strains of tuberculosis with resistance to multiple drugs could spread widely and highlighted an annual need of...Read more
-
Edison Pharma, DSP enter $4 bn metablosim drug deal
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 04 Feb, 2014
Singapore: US-based Edison Pharmaceuticals has entered into a strategic alliance valued up to $4.295 billion with Japan's Dainippon Sumitomo Pharma (DSP) for the development of drugs target...Read more
-
Gilead files NDA for Hep C drug in Japan
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 30 Jun, 2014
Singapore: US-based Gilead Sciences has submitted a New Drug Application (NDA) to Japan's Pharmaceutical and Medical Devices Agency (PMDA) for approval of sofosbuvir, a once-daily nucleotid...Read more
-
GSK gets EU nod for metastatic melanoma inhibitor
Drug Discovery | Regulatory | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2013
Singapore: GlaxoSmithKline has recieved European Commission (EC) marketing authorisation for Mekinist (trametinib) as a single agent in the treatment of adult patients with unresectable or ...Read more
-
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2013
Singapore: Brisbane drug discovery and development company Alchemia announces that Mr Charles Walker has been appointed to the position of Chief Executive Officer. Mr Charles (Charlie) Wa...Read more
-
Merck Millipore enhances bioavailability portfolio
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 10 Oct, 2012
Singapore: Merck Millipore is boosting its portfolio for drug bioavailability, including products for all types of dosage forms that address solubility, and PK/PD modification and targeting...Read more
-
Singapore scientists, clinicians collaborate on 8 projects
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2012
Singapore: Singapore has announced 8 biomedical sciences research programmes to advance understanding and treatment of diseases especially prevalent amongst the Asian population. These prog...Read more
-
Boehringer Ingelheim enriches drug pipeline
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 24 Jul, 2012
Singapore: Boehringer Ingelheim, one of the world's leading pharmaceutical companies, will acquire the global rights of a clinical-stage company, Funxional Therapeutics' FX125L compound and...Read more
-
China will overtake Japan in R&D spending: Report
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 08 Aug, 2013
Singapore: China's biomedical sector is rapidly transforming itself from a manufacturing base to an innovation hub, investing billions of dollars and setting up innovation centers in a bid ...Read more
-
Astellas gets FDA nod for kidney transplant drug
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 22 Jul, 2013
Singapore: Japan-based Astellas Pharma has received US FDA approval for Astagraf XL (tacrolimus extended-release capsules) for the prophylaxis of organ rejection in patients receiving a kid...Read more
-
Global collaborations is the way forward for drug discovery
Drug Discovery | Analysis | By BioSpectrum Bureau | 0 Comment | 19 Dec, 2012
Over the last few decades India has reiterated its capabilities in providing dependable and cost effective chemistry services to big pharma through a multitude of outsourcing deals. A large...Read more
-
NIH gives $2.2 mn to VaxInnate for dengue vaccine
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 05 Apr, 2013
Singapore: National Institutes of Health's (NIH) National Institute of Allergy and Infectious Diseases (NIAID) has provided funds worth $2.2 million to US based-novel vaccine firm VaxInnate...Read more
-
Janssen to develop therapy for immunological diseases
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2012
Singapore: Janssen Biotech has entered into a license agreement with Astellas Pharma for the worldwide development and commercialization, except in Japan, of ASP015K, an oral, small molecul...Read more
